Quantcast
Last updated on April 21, 2014 at 5:04 EDT

Latest Trigeminal neuralgia Stories

2014-02-27 18:19:38

Research results published in the Clinical Neurology and Neuroscience journal Research by Beaumont Health System radiation oncologists and neurosurgeons found that symptoms of trigeminal neuralgia, or TN, a nerve disorder causing severe facial pain, were reduced in those treated with Gamma Knife stereotactic radiosurgery. The results were published in the February issue of the journal Clinical Neurology and Neurosurgery. TN is a disorder of the trigeminal nerve, which is responsible for...

2014-02-26 20:22:09

Using ultrasound guidance for facial injection is highly effective in treating trigeminal neuralgia CHICAGO, Feb. 26, 2014 /PRNewswire-USNewswire/ -- Cold wind was the trigger to pain greater than Paula Fore could have ever imagined, an electrical-feeling jolt that appeared suddenly and without warning on the left side of her face. "This pain is real," said Paula Fore, 49, a beauty shop owner, amateur motorcycle racer and grandmother of three from Washington, Ill., who started...

2014-02-19 08:32:39

LONDON, Feb. 19, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: EpiCast Report: Trigeminal Neuralgia - Epidemiology Forecast to 2022 EpiCast Report: Trigeminal Neuralgia - Epidemiology Forecast to 2022 Summary Trigeminal neuralgia, also called tic douloureux, is a chronic nerve disorder characterized by severe facial nerve. The condition is more common in women compared with men and most commonly affects people ages 50 years and older. Globally...

2014-01-23 23:27:27

Meniere's Disease & Trigeminal Neuralgia Breakthrough; a Story of Survival! Learn about important traditional & complementary alternatives to one-sided neurological problems like Meniere's disease, Trigeminal neuralgia, Glossopharyngeal neuralgia, Bell's palsy, Parkinson's disease & migraines. (PRWEB) January 23, 2014 The featured speaker at this year’s Meniere's Disease Research Institute's Workshop is Dr. Michael T. Burcon, B.Ph., D.C., world's...

2013-11-20 08:29:19

Country's sole Leksell Gamma Knife system used in treatments of over 6,000 patients since 1993 MADRID, Nov. 20, 2013 /PRNewswire/ -- In 1993, Hospital Ruber Internacional became the world's 43(rd )Leksell Gamma Knife® center, treating its first patient - a 60-year-old female patient with a frontal meningioma - on August 23 of that year. Both the patient and the hospital's Radiosurgery and Functional Neurosurgery Unit are still going strong today. Operating Spain's only Gamma Knife...

2013-10-08 08:29:17

AACHEN, Germany, October 8, 2013 /PRNewswire/ -- - A new website helps pain patients to better express and explain how their pain feels like Pain can appear in many forms and affects people in different ways. One kind of long-lasting or chronic pain results from a damaged nerve that sends incorrect pain messages to the brain. This pain is called neuropathic pain or nerve pain. Over 26 million people worldwide suffer from neuropathic pain[1] but only 40-60% of...

2013-07-30 04:21:16

CAMBRIDGE, England, July 30, 2013 /PRNewswire/ -- Designation granted by US FDA for the treatment of trigeminal neuralgia Convergence Pharmaceuticals Limited ("Convergence" or "the company"), the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, is pleased to announce that its novel sodium channel blocker, CNV1014802 ('802), has been granted orphan-drug designation by the US Food and Drug...

2013-05-22 23:24:15

Meniere's Disease & Trigeminal Neuralgia Breakthrough; a Story of Survival! Learn about important traditional & complementary alternatives to one-sided neurological problems. Grand Rapids, MI (PRWEB) May 22, 2013 The featured speaker at this year´s Meniere's Disease Research Institute's Workshop is Dr. Michael T. Burcon, world's leading expert on Meniere's disease (MD). Burcon has proven a correlation between MD and whiplash (caused by a vehicular accident or a fall on the...

2013-05-20 08:28:22

Chief Scientist Will Also Be Presenting at 4th International Congress on Neuropathic Pain in Toronto LONDON, May 20, 2013 /PRNewswire/ -- Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, today announced that David C. Yeomans, Ph.D., Chief Scientist and Founder, as well as the Director of Pain Research at Stanford University School of Medicine, will be giving two presentations today at...

2013-04-15 14:19:21

Minimally invasive cryoneurolysis alleviates chronic pain Using a tiny ball of ice, a minimally invasive interventional radiology treatment called cryoneurolysis safely short circuits chronic pain caused by nerve damage, according to data being presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans. "Cryoneurolysis could have big implications for the millions of people who suffer from neuralgia, which can be unbearable and is very difficult...